About Meenal Lele
Form D filings for Hanimune Therapeutics from 2019 to 2023 list Meenal Lele as chief executive officer and director.
Meenal Lele first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Meenal Lele in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Meenal Lele works with at each company, as listed on that company's latest Form D.
Hanimune Therapeutics Inc · Form D, Feb 7, 2023
HM
Hany Michail
Director